Loerop James

Aclaris Therapeutics, Inc. · Chief Business Officer

Loerop James is listed in public filings as officer: Chief Business Officer. This Loerop James insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Aclaris Therapeutics, Inc. (ACRS). Investors use Loerop James's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Aclaris Therapeutics, Inc.ACRS	--62.6k shares	Grant / ExerciseFeb 3, 2026	Disclosure amount unavailable20.9k shares	--	--
Aclaris Therapeutics, Inc.ACRS	$667k192.3k shares	Grant / ExerciseFeb 3, 2026	$20.6K5.9k shares	$3.47	--

Insider Trades History

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Aclaris Therapeutics, Inc.ACRS	$1.2M341.9k shares	Grant / ExerciseFeb 2, 2026	$1.2M341.9k shares	$3.61	--
Aclaris Therapeutics, Inc.ACRS	--97.7k shares	Grant / ExerciseFeb 2, 2026	Disclosure amount unavailable97.7k shares	--	--
Aclaris Therapeutics, Inc.ACRS	--11.3k shares	Grant / ExerciseFeb 1, 2026	Disclosure amount unavailable11.3k shares	--	--
Aclaris Therapeutics, Inc.ACRS	--7.5k shares	Grant / ExerciseFeb 1, 2026	Disclosure amount unavailable7.5k shares	--	--
Aclaris Therapeutics, Inc.ACRS	--29.5k shares	Grant / ExerciseFeb 1, 2026	Disclosure amount unavailable14.8k shares	--	--
Aclaris Therapeutics, Inc.ACRS	$622k177.3k shares	Grant / ExerciseFeb 1, 2026	$37.5K10.7k shares	$3.51	--
Aclaris Therapeutics, Inc.ACRS	--18.7k shares	Grant / ExerciseJan 2, 2026	Disclosure amount unavailable18.2k shares	--	--
Aclaris Therapeutics, Inc.ACRS	$447k155k shares	Grant / ExerciseJan 2, 2026	$17.8K6.2k shares	$2.88	--
Aclaris Therapeutics, Inc.ACRS	--73.8k shares	Grant / ExerciseDec 31, 2025	Disclosure amount unavailable73.8k shares	--	--
Aclaris Therapeutics, Inc.ACRS	$431k143.1k shares	Grant / ExerciseDec 31, 2025	$102.3K34k shares	$3.01	--
Aclaris Therapeutics, Inc.ACRS	$702k292.3k shares	Grant / ExerciseFeb 3, 2025	$701.5K292.3k shares	$2.40	--
Aclaris Therapeutics, Inc.ACRS	--83.5k shares	Grant / ExerciseFeb 3, 2025	Disclosure amount unavailable83.5k shares	--	--
Aclaris Therapeutics, Inc.ACRS	--11.3k shares	Grant / ExerciseFeb 1, 2025	Disclosure amount unavailable11.3k shares	--	--
Aclaris Therapeutics, Inc.ACRS	--15k shares	Grant / ExerciseFeb 1, 2025	Disclosure amount unavailable7.5k shares	--	--
Aclaris Therapeutics, Inc.ACRS	--44.3k shares	Grant / ExerciseFeb 1, 2025	Disclosure amount unavailable14.8k shares	--	--
Aclaris Therapeutics, Inc.ACRS	$255k102.8k shares	Grant / ExerciseFeb 1, 2025	$39.6K16k shares	$2.48	--
Aclaris Therapeutics, Inc.ACRS	$256k103.3k shares	Grant / ExerciseFeb 1, 2025	$38.3K15.4k shares	$2.48	--
Aclaris Therapeutics, Inc.ACRS	--36.9k shares	Grant / ExerciseJan 2, 2025	Disclosure amount unavailable18.2k shares	--	--
Aclaris Therapeutics, Inc.ACRS	--55k shares	Grant / ExerciseJan 2, 2025	Disclosure amount unavailable55k shares	--	--
Aclaris Therapeutics, Inc.ACRS	$211k85.3k shares	Grant / ExerciseJan 2, 2025	$21.3K8.6k shares	$2.48	--
Aclaris Therapeutics, Inc.ACRS	--73.8k shares	Grant / ExerciseDec 31, 2024	Disclosure amount unavailable73.8k shares	--	--
Aclaris Therapeutics, Inc.ACRS	$188k75.7k shares	Grant / ExerciseDec 31, 2024	$79.6K32.1k shares	$2.48	--